Chris Zink, DVM, PhD, DACVP, DACVSMR

University Distinguished Service Professor

410-955-9770

Miller Research Building, Room 835


 

Education

DVM Universty of Guelph, Ontario Veterinary College
PhD Universty of Guelph, Ontario Veterinary College
Postdoctoral Fellowship Johns Hopkins University, Baltimore MD
Dip. ACVP

About

Dr. Zink has been studying the pathogenesis of lentiviral infections for over 30 years. Drs. Zink, Clements, and Mankowski developed a highly reproducible, rapid SIV/macaque model of HIV that faithfully reproduces all the key features of HIV infection and cART therapy, as well as residual CNS inflammation in individuals on cART therapy. This model is ideal for rigorous testing of novel drugs for amelioration of residual/persistent CNS manifestations and of drugs to activate virus with the goal of virus eradication. Dr. Zink has published extensively on the pathogenic mechanisms of HIV/SIV as well as the host defenses and responses to viral infection using this and other animal models as well as human blood/CSF samples and tissues. She has served on numerous study sections, and held numerous leadership positions both at Johns Hopkins and nationally, and has an international reputation in the field of HIV/SIV. Dr. Zink currently plays a clinical and teaching role for graduate students and postdoctoral fellows in the Department of Molecular and Comparative Pathobiology and assists in the preparation and review of grant applications and manuscripts